Platelet secretion: From haemostasis to wound healing and beyond

Coller, 2011, Historical perspective and future directions in platelet research, J Thromb Haemost, 9, 374, 10.1111/j.1538-7836.2011.04356.x

Rumbaut, 2010, Platelet–vessel wall interactions in hemostasis and thrombosis

Duckers, 2010, Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms, Blood, 115, 879, 10.1182/blood-2009-08-237719

Coppinger, 2004, Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions, Blood, 103, 2096, 10.1182/blood-2003-08-2804

Gosk-Bierska, 2011, Platelet factor XIII gene expression and embolic propensity in atrial fibrillation, Thromb Haemost, 106, 75, 10.1160/TH10-11-0765

Ghosh, 2013, Inositol hexakisphosphate kinase 1 maintains hemostasis in mice by regulating platelet polyphosphate levels, Blood, 122, 1478, 10.1182/blood-2013-01-481549

Morrissey, 2012, Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation, Blood, 119, 5972, 10.1182/blood-2012-03-306605

Maynard, 2007, Proteomic analysis of platelet alpha-granules using mass spectrometry, J Thromb Haemost, 5, 1945, 10.1111/j.1538-7836.2007.02690.x

Meyers, 1982, Comparative study of platelet dense granule constituents, Am J Physiol, 243, R454

Jonnalagadda, 2012, Platelet secretion is kinetically heterogeneous in an agonist-responsive manner, Blood, 120, 5209, 10.1182/blood-2012-07-445080

Andre, 2003, P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries, J Clin Invest, 112, 398, 10.1172/JCI17864

Ren, 2010, Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasis, Blood, 116, 869, 10.1182/blood-2010-02-270934

Savage, 2013, Munc13-4 is critical for thrombosis through regulating release of ADP from platelets, J Thromb Haemost, 11, 771, 10.1111/jth.12138

Stegner, 2013, Munc13-4-mediated secretion is essential for infarct progression but not intracranial hemostasis in acute stroke, J Thromb Haemost, 11, 1430, 10.1111/jth.12293

van der Meijden, 2005, Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk, Thromb Haemost, 93, 1128, 10.1160/TH04-09-0597

Nesbitt, 2009, A shear gradient-dependent platelet aggregation mechanism drives thrombus formation, Nat Med, 15, 665, 10.1038/nm.1955

Maxwell, 2007, Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation, Blood, 109, 566, 10.1182/blood-2006-07-028282

Hechler, 2010, Arterial thrombosis: relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization, J Thromb Haemost, 8, 173, 10.1111/j.1538-7836.2009.03666.x

Stalker, 2013, Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network, Blood, 121, 1875, 10.1182/blood-2012-09-457739

Welsh, 2012, Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse, J Thromb Haemost, 10, 2344, 10.1111/j.1538-7836.2012.04928.x

Pudusseri, 2013, A new paradigm shift in antithrombotic therapy, Front Pharmacol, 4, 133, 10.3389/fphar.2013.00133

Becker, 2011, Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial, Eur Heart J, 32, 2933, 10.1093/eurheartj/ehr422

Wang, 2013, Inorganic polyphosphates: biologically active biopolymers for biomedical applications, Prog Mol Subcell Biol, 54, 261, 10.1007/978-3-642-41004-8_10

Muller, 2009, Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo, Cell, 139, 1143, 10.1016/j.cell.2009.11.001

Mackman, 2010, Platelet polyphosphate: an endogenous activator of coagulation factor XII, J Thromb Haemost, 8, 865, 10.1111/j.1538-7836.2010.03832.x

Morrissey, 2004, Tissue factor: a key molecule in hemostatic and nonhemostatic systems, Int J Hematol, 79, 103, 10.1532/IJH97.03167

Smith, 2006, Polyphosphate modulates blood coagulation and fibrinolysis, Proc Natl Acad Sci U S A, 103, 903, 10.1073/pnas.0507195103

Smith, 2008, Polyphosphate enhances fibrin clot structure, Blood, 112, 2810, 10.1182/blood-2008-03-145755

Smith, 2012, Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation, Blood, 120, 5103, 10.1182/blood-2012-07-444935

Jain, 2012, Nucleic acid scavengers inhibit thrombosis without increasing bleeding, Proc Natl Acad Sci U S A, 109, 12938, 10.1073/pnas.1204928109

Blair, 2009, Platelet alpha-granules: basic biology and clinical correlates, Blood Rev, 23, 177, 10.1016/j.blre.2009.04.001

Kuijpers, 2014, Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagen, Arterioscler Thromb Vasc Biol, 34, 1187, 10.1161/ATVBAHA.113.302917

Camire, 1995, The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals, J Biol Chem, 270, 20794, 10.1074/jbc.270.35.20794

Gould, 2004, Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va, J Biol Chem, 279, 2383, 10.1074/jbc.M308600200

Hu, 1998, Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression, Blood, 91, 3800, 10.1182/blood.V91.10.3800

Machlus, 2013, The incredible journey: from megakaryocyte development to platelet formation, J Cell Biol, 201, 785, 10.1083/jcb.201304054

Ambrosio, 2012, Mechanism of platelet dense granule biogenesis: study of cargo transport and function of Rab32 and Rab38 in a model system, Blood, 120, 4072, 10.1182/blood-2012-04-420745

Heijnen, 1998, Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules, Blood, 91, 2313, 10.1182/blood.V91.7.2313

Huizing, 2008, Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics, Annu Rev Genomics Hum Genet, 9, 359, 10.1146/annurev.genom.9.081307.164303

Fontana, 2006, Innate immunity defects in Hermansky–Pudlak type 2 syndrome, Blood, 107, 4857, 10.1182/blood-2005-11-4398

Shotelersuk, 1998, Hermansky–Pudlak syndrome: models for intracellular vesicle formation, Mol Genet Metab, 65, 85, 10.1006/mgme.1998.2729

Davies, 1976, Familial pulmonary fibrosis associated with oculocutaneous albinism and platelet function defect. A new syndrome, Q J Med, 45, 219

Nurden, 2012, Inherited platelet disorders, Haemophilia, 18, 154, 10.1111/j.1365-2516.2012.02856.x

Nurden, 2011, Advances in our understanding of the molecular basis of disorders of platelet function, J Thromb Haemost, 9, 76, 10.1111/j.1538-7836.2011.04274.x

Masliah-Planchon, 2013, Molecular determinants of platelet delta storage pool deficiencies: an update, Brit J Haematol, 160, 5, 10.1111/bjh.12064

Kaplan, 2008, Chediak–Higashi syndrome, Curr Opin Hematol, 15, 22, 10.1097/MOH.0b013e3282f2bcce

Cullinane, 2013, The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease, Traffic, 14, 749, 10.1111/tra.12069

Nieuwenhuis, 1987, Patients with a prolonged bleeding-time and normal aggregation tests may have storage pool deficiency — studies on 106 patients, Blood, 70, 620, 10.1182/blood.V70.3.620.620

Nurden, 2007, The gray platelet syndrome: clinical spectrum of the disease, Blood Rev, 21, 21, 10.1016/j.blre.2005.12.003

Albers, 2011, Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome, Nat Genet, 43, 735, 10.1038/ng.885

Gunay-Aygun, 2011, NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet alpha-granules, Nat Genet, 43, 732, 10.1038/ng.883

Kahr, 2011, Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome, Nat Genet, 43, 738, 10.1038/ng.884

Deppermann, 2013, Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice, J Clin Invest, 10.1172/JCI69210

Kahr, 2013, Abnormal megakaryocyte development and platelet function in Nbeal2(−/−) mice, Blood, 122, 3349, 10.1182/blood-2013-04-499491

Gissen, 2004, Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome, Nat Genet, 36, 400, 10.1038/ng1325

Blavignac, 2011, Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment, Semin Thromb Hemost, 37, 713, 10.1055/s-0031-1291382

Kahr, 2001, Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator, Blood, 98, 257, 10.1182/blood.V98.2.257

Sudhof, 2009, Membrane fusion: grappling with SNARE and SM proteins, Science, 323, 474, 10.1126/science.1161748

Golebiewska, 2014, Secrets of platelet exocytosis — what do we really know about platelet secretion mechanisms?, Brit J Haematol, 165, 204, 10.1111/bjh.12682

Lemons, 1997, Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery, Blood, 90, 1490, 10.1182/blood.V90.4.1490

Murata, 2011, Rapid diagnosis of FHL3 by flow cytometric detection of intraplatelet Munc13-4 protein, Blood, 118, 1225, 10.1182/blood-2011-01-329540

Ye, 2012, Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion, Blood, 120, 2484, 10.1182/blood-2012-05-430603

Al Hawas, 2012, Munc18b/STXBP2 is required for platelet secretion, Blood, 120, 2493, 10.1182/blood-2012-05-430629

zur Stadt, 2009, Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11, Am J Hum Genet, 85, 482, 10.1016/j.ajhg.2009.09.005

Chen, 2000, Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 in dense core granule release, Blood, 95, 921, 10.1182/blood.V95.3.921.003k17_921_929

Chen, 2000, Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 and 4 in lysosome release, Blood, 96, 1782, 10.1182/blood.V96.5.1782

Karim, 2013, IkappaB kinase phosphorylation of SNAP-23 controls platelet secretion, Blood, 121, 4567, 10.1182/blood-2012-11-470468

Polgar, 2003, Phosphorylation of SNAP-23 in activated human platelets, J Biol Chem, 278, 44369, 10.1074/jbc.M307864200

Ren, 2007, Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction, Mol Biol Cell, 18, 24, 10.1091/mbc.E06-09-0785

Zarbock, 2007, Platelet–neutrophil-interactions: linking hemostasis and inflammation, Blood Rev, 21, 99, 10.1016/j.blre.2006.06.001

Gleissner, 2008, Platelet chemokines in vascular disease, Arterioscler Thromb Vasc Biol, 28, 1920, 10.1161/ATVBAHA.108.169417

Xia, 2003, Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells, Int Immunol, 15, 1007, 10.1093/intimm/dxg100

Kasper, 2006, Neutrophil adhesion to endothelial cells induced by platelet factor 4 requires sequential activation of Ras, Syk, and JNK MAP kinases, Blood, 107, 1768, 10.1182/blood-2005-06-2501

von Hundelshausen, 2005, Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium, Blood, 105, 924, 10.1182/blood-2004-06-2475

Gawaz, 2005, Platelets in inflammation and atherogenesis, J Clin Invest, 115, 3378, 10.1172/JCI27196

Duerschmied, 2013, Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice, Blood, 121, 1008, 10.1182/blood-2012-06-437392

Lam, 2011, Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1, Am J Physiol Heart Circ Physiol, 300, H468, 10.1152/ajpheart.00491.2010

Ghasemzadeh, 2013, The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi, Blood, 121, 4555, 10.1182/blood-2012-09-459636

Koenen, 2009, Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice, Nat Med, 15, 97, 10.1038/nm.1898

Thompson, 1982, The role of bacterial adherence in the pathogenesis of infective endocarditis, Infection, 10, 196, 10.1007/BF01640778

Tang, 2002, Antimicrobial peptides from human platelets, Infect Immun, 70, 6524, 10.1128/IAI.70.12.6524-6533.2002

Youssefian, 2002, Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation, Blood, 99, 4021, 10.1182/blood-2001-12-0191

Clemetson, 2011, The role of platelets in defence against pathogens, Hamostaseologie, 31, 264, 10.5482/ha-1152

Berthet, 2012, Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion, Clin Immunol, 145, 189, 10.1016/j.clim.2012.09.004

Yeaman, 2014, Platelets: at the nexus of antimicrobial defence, Nat Rev Microbiol, 12, 426, 10.1038/nrmicro3269

Li, 2011, PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms, J Cell Biochem, 112, 289, 10.1002/jcb.22924

Liu, 1989, Restenosis after coronary angioplasty — potential biologic determinants and role of intimal hyperplasia, Circulation, 79, 1374, 10.1161/01.CIR.79.6.1374

Andrae, 2008, Role of platelet-derived growth factors in physiology and medicine, Gene Dev, 22, 1276, 10.1101/gad.1653708

Massberg, 2006, Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo, J Exp Med, 203, 1221, 10.1084/jem.20051772

Xu, 2013, Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization, Cells Tissues Organs, 197, 103, 10.1159/000342921

Stellos, 2008, Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells, Circulation, 117, 206, 10.1161/CIRCULATIONAHA.107.714691

Bermudez, 2011, Inhibition of stromal cell-derived factor-1alpha further impairs diabetic wound healing, J Vasc Surg, 53, 774, 10.1016/j.jvs.2010.10.056

Daub, 2006, Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells, FASEB J, 20, 2559, 10.1096/fj.06-6265fje

Petit, 2007, The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis, Trends Immunol, 28, 299, 10.1016/j.it.2007.05.007

De Falco, 2004, SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells, Blood, 104, 3472, 10.1182/blood-2003-12-4423

Salvucci, 2002, Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1, Blood, 99, 2703, 10.1182/blood.V99.8.2703

Battinelli, 2011, Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis, Blood, 118, 1359, 10.1182/blood-2011-02-334524

Gawaz, 2013, Platelets in tissue repair: control of apoptosis and interactions with regenerative cells, Blood, 122, 2550, 10.1182/blood-2013-05-468694

Nurden, 2008, Platelets and wound healing, Front Biosci, 13, 3532

Gasic, 1968, Antimetastatic effects associated with platelet reduction, Proc Natl Acad Sci U S A, 61, 46, 10.1073/pnas.61.1.46

Ho-Tin-Noe, 2008, Platelet granule secretion continuously prevents intratumor hemorrhage, Cancer Res, 68, 6851, 10.1158/0008-5472.CAN-08-0718

Erpenbeck, 2010, Deadly allies: the fatal interplay between platelets and metastasizing cancer cells, Blood, 115, 3427, 10.1182/blood-2009-10-247296

Yu, 2003, Platelet-derived growth factor signaling and human cancer, J Biochem Mol Biol, 36, 49, 10.5483/BMBRep.2003.36.1.049

Carvalho, 2005, Overexpression of platelet-derived growth factor receptor a in breast cancer is associated with tumour progression, Breast Cancer Res, 7, R788, 10.1186/bcr1304

Zhang, 2012, Platelet-derived growth factor receptor-alpha promotes lymphatic metastases in papillary thyroid cancer, J Pathol, 228, 241, 10.1002/path.4069

Dvorak, 1995, Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation, Int Arch Allergy Immunol, 107, 233, 10.1159/000236988

Goel, 2013, VEGF targets the tumour cell, Nat Rev Cancer, 13, 871, 10.1038/nrc3627

Labelle, 2011, Direct signaling between platelets and cancer cells induces an epithelial–mesenchymal-like transition and promotes metastasis, Cancer Cell, 20, 576, 10.1016/j.ccr.2011.09.009

Bambace, 2011, The platelet contribution to cancer progression, J Thromb Haemost, 9, 237, 10.1111/j.1538-7836.2010.04131.x

Wang, 2013, Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy, Cancer Lett, 331, 147, 10.1016/j.canlet.2013.01.006

Schumacher, 2013, Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor, Cancer Cell, 24, 130, 10.1016/j.ccr.2013.05.008

Harper, 2013, Comment on “Platelet-derived nucleotides promote tumor cell transendothelial migration and metastasis via P2Y(2) receptor” by Schumacher et al, Cancer Cell, 24, 287, 10.1016/j.ccr.2013.08.016

Li, 2011, Platelets as immune mediators: their role in host defense responses and sepsis, Thromb Res, 127, 184, 10.1016/j.thromres.2010.10.010

Nachman, 2008, Platelets, petechiae, and preservation of the vascular wall, N Engl J Med, 359, 1261, 10.1056/NEJMra0800887

Lee, 2010, Sepsis and endothelial permeability, N Engl J Med, 363, 689, 10.1056/NEJMcibr1007320

Morrell, 2007, Platelets an inflammatory force in transplantation, Am J Transplant, 7, 2447, 10.1111/j.1600-6143.2007.01958.x

Valenzuela, 2013, Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo, Am J Transplant, 13, 299, 10.1111/ajt.12016

Zarbock, 2009, The role of platelets in acute lung injury (ALI), Front Biosci (Landmark Ed), 14, 150, 10.2741/3236

Grommes, 2012, Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury, Am J Respir Crit Care Med, 185, 628, 10.1164/rccm.201108-1533OC

McCormack, 2001, Tissue cytokine and chemokine expression in inflammatory bowel disease, Inflamm Res, 50, 491, 10.1007/PL00000223

Waeber, 2005, Migraine as an inflammatory disorder, Neurology, 64, S9, 10.1212/WNL.64.10_suppl_2.S9

Ulfman, 2003, Platelets promote eosinophil adhesion of patients with asthma to endothelium under flow conditions, Am J Respir Cell Mol, 28, 512, 10.1165/rcmb.4806

Ma, 2005, Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets, Proc Natl Acad Sci U S A, 102, 216, 10.1073/pnas.0406682102

Sehgal, 2007, Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release, J Thromb Haemost, 5, 2009, 10.1111/j.1538-7836.2007.02698.x

Italiano, 2008, Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released, Blood, 111, 1227, 10.1182/blood-2007-09-113837

Kamykowski, 2011, Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet alpha-granules, Blood, 118, 1370, 10.1182/blood-2011-01-330910

van Nispen tot Pannerden, 2010, The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes, Blood, 116, 1147, 10.1182/blood-2010-02-268680

Kreykenbohm, 2002, The SNAREs vti1a and vti1b have distinct localization and SNARE complex partners, Eur J Cell Biol, 81, 273, 10.1078/0171-9335-00247

Mollinedo, 2006, Combinatorial SNARE complexes modulate the secretion of cytoplasmic granules in human neutrophils, J Immunol, 177, 2831, 10.4049/jimmunol.177.5.2831

Morgenstern, 1998, The pathway of exocytosis in human platelets, Blood, 92, 2191, 10.1182/blood.V92.6.2191